Skip to main content

Advertisement

Table 3 Event, Maintenance and therapy costs (indexed to £UK 2007)

From: Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom

Variable Cost Source
Ischaemic Heart Disease, fatal event £0 UKPDS Study No.65†
Ischaemic Heart Disease, Non-fatal event £2,388 UKPDS Study No.65†
Ischaemic Heart Disease, Maintenance £601 UKPDS Study No.65†
Myocardial Infarction, Fatal event £1,404 UKPDS Study No 65†
Myocardial Infarction, Non-fatal event £4,961 UKPDS Study No.65†
Myocardial Infarction, Maintenance £566 UKPDS Study No.65†
Congestive Heart Failure, Fatal event £0 UKPDS Study No.65†
Congestive Heart Failure, Non fatal event £2,707 UKPDS Study No.65†
Congestive Heart Failure, Maintenance £769 UKPDS Study No.65†
Stroke, Fatal event £4,124 UKPDS Study No.65†
Stroke, Non-fatal event £2,885 UKPDS Study No.65†
Stroke, Maintenance £304 UKPDS Study No.65†
Blindness, Event 0 O'Brien et al. [37]
Blindness, Maintenance £1,013 O'Brien et al. [37]
Dialysis, Event and Maintenance £20,049 Baboolal et al. [38]
Amputation, Fatal event £10,311 UKPDS Study No.65†
Amputation, Non-fatal event £10,311 UKPDS Study No.65†
Amputation, Maintenance £366 UKPDS Study No.65†
Hypoglycaemia, Event £93.85 Leese GP et al. [6]; DCCT hypoglycaemia report*
  1. † Data from: Clarke P, Gray A, Legood R, Briggs A, Holman R: The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabetic Medicine 2003, 20:442–450.
  2. * Data from: The DCCT Research Group: Epidemiology of severe hypoglycemia in the diabetes control and complications trial. American Journal of Medicine 1991, 90:450–459.